IP Library Assignment 027691/0525
Patent Assignment
Reel/Frame 027691/0525

Corrective Assignment to Correct the Application Serial Number 13/299862 Previously Recorded on Reel 027675 Frame 0229. Assignor(S) Hereby Confirms the Correct Serial Number 13/229862.

Recorded: 2012-02-13 Pages: 40
Assignors
GREENSMITH, LINDA
Executed: 2003-11-03
BURNSTOCK, GEOFFREY
Executed: 2003-10-29
Assignee
BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
8200 VESZPREM, SZABADSAGPUSZTA, HUNGARY
Covered Property (1)
Use of a Hydroximic Acid Halide Derivative in the Treatment of Neurodegenerative Diseases
Patent: 8,962,604 →
Application: 13/229,862 →
Publication: US 2012/0115908
Related Assignments (10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 8, 2012
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 027671/0697 →
Assignment of Assignor's Interest Feb 8, 2012
From: URBANICS, RUDOLF
To: CYTRX CORPORATION
Reel/Frame 027671/0717 →
Assignment of Assignor's Interest Feb 8, 2012
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 027671/0739 →
Assignment of Assignor's Interest Feb 8, 2012
From: GREENSMITH, LINDA; BURNSTOCK, GEOFFREY
To: BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
Reel/Frame 027675/0229 →
Corrective Assignment to Correct the Application Serial Number 13/299862 Previously Recorded on Reel 027671 Frame 0697. Assignor(S) Hereby Confirms the Correct Serial Number 13/229862. Feb 9, 2012
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 027682/0713 →
Change of Name Apr 11, 2018
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 045911/0992 →
Security Interest Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Assignment of Assignor's Interest Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →
Release of Security Interest Apr 4, 2024
From: KREOS CAPITAL VI (UK) LIMITED
To: ZEVRA DENMARK A/S (F/K/A KEMPHARM DENMARK A/S, SUCCESSOR IN INTEREST TO ORPHAZYME A/S)
Reel/Frame 067007/0706 →